CHOITEC

Founded in 2017, Hainan ChoiteC Pharmaceuticals Co. Ltd. is a high-tech pharmaceutical enterprise focused on the research, development, and production of active pharmaceutical ingredients (APIs) and anti-tumor preparations. The company provides end-to-end solutions, encompassing project approval, R&D, registration, production, and sales. Its business model includes contract manufacturing organization (CMO) services and original equipment manufacturer (OEM) processing for products like sterile freeze-dried powders and injections.

CHOITEC operates multiple GMP-certified production lines with significant annual capacity, including 25 million pieces each of lyophilized powder and aqueous injections. The company's main products include fluorouracil, vidarabine monophosphate, and ketorolac tromethamine. CHOITEC serves other pharmaceutical enterprises and R&D units through partnerships and a business development team that engages in licensing, technology transfers, and asset purchases. The firm has established specialized technology platforms for enzyme reactions and microchannel reactions to support green and environmentally friendly drug development and production.

Keywords: anti-tumor preparations, active pharmaceutical ingredients, API manufacturing, contract manufacturing organization, CMO, pharmaceutical R&D, GMP-certified, sterile injectables, lyophilized powder, fluorouracil, oncology pharmaceuticals, pharmaceutical technology platforms, drug development, OEM pharmaceutical, sterile drugs, drug registration, clinical development, pharmaceutical sales, green chemistry, enzyme reaction technology